Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polycystin-1-like protein 1 (PKD1L1) is a member of the polycystin protein family encoded by the PKD1L1 gene[2][4]. It is a transmembrane protein featuring 11 membrane-spanning domains, a large extracellular region with two immunoglobulin-like polycystic kidney disease (PKD) domains, a receptor for egg jelly (REJ) domain, a GPS proteolysis site, a PLAT domain, and an intracellular coiled-coil region[2][4][6]. PKD1L1 functions as a component of a ciliary calcium-permeant ion channel complex that regulates calcium concentration within primary cilia, often via interaction and colocalization with the similar protein PKD2[2][6][8]. PKD1L1 has both channel-like and adhesion GPCR features; certain isoforms contain motifs typical of rhodopsin-like GPCRs and interact with G-protein signaling pathways[6][5]. Biologically, PKD1L1 is crucial for establishing left–right asymmetry during embryonic development, with loss-of-function mutations linked to laterality disorders including situs inversus and heterotaxy, which can cause congenital heart defects[4]. It is also expressed in the testis (especially Leydig cells) and the fetal/adult heart[2]. PKD1L1 plays a role in signal transduction, ciliary calcium signaling, protein–protein/cell–cell interactions, cell adhesion, and possibly mechano/force sensing[2][4][5]. No clinically approved drugs directly targeting PKD1L1 have been described in the literature, nor are biomarkers or specific safety concerns established at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polycystin-1-like protein 1 (PKD1L1).